AGN-190584 ophthalmic solution
Sponsors
Allergan
Conditions
Presbyopia
Phase 2
A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia
CompletedNCT02595528
Start: 2016-04-29End: 2017-10-18Updated: 2020-12-22
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
CompletedNCT02780115
Start: 2016-05-26End: 2017-10-31Updated: 2020-12-22